Brown F R, Voigt R, Singh A K, Singh I
Meyer Center for Developmental Pediatrics, Texas Children's Hospital, Houston 77030.
Am J Dis Child. 1993 Jun;147(6):617-26. doi: 10.1001/archpedi.1993.02160300023015.
The peroxisomal disorders represent a group of inherited metabolic disorders that derive from defects of peroxisomal biogenesis and/or from dysfunction of single or multiple peroxisomal enzymes. Because peroxisomes are involved in the metabolism of lipids critical to the functioning of the nervous system, many of the peroxisomal disorders manifest with significant degrees of progressive psychomotor dysfunction. These disorders should be considered in the differential diagnosis of the infant with hypotonia and psychomotor delay (especially if accompanied by facial dysmorphisms, hepatomegaly, cataracts and/or retinitis, calcific stippling, short limbs, or combinations of these features), in the school-aged child with progressive neurologic dysfunction, and in adults with slowly progressive motor dysfunction. Current knowledge of peroxisomal biochemical and enzymatic processes permits precise identification of particular disorders within the peroxisomal disorder grouping. An effort should be made to identify the specific peroxisomal disorder to provide a precise explanation for neurodevelopmental deficits, to potentially prevent recurrence through genetic counseling, and to provide appropriate therapies when available.
过氧化物酶体病是一组遗传性代谢疾病,源于过氧化物酶体生物发生缺陷和/或单一或多种过氧化物酶体酶功能障碍。由于过氧化物酶体参与对神经系统功能至关重要的脂质代谢,许多过氧化物酶体病表现为严重程度的进行性精神运动功能障碍。对于肌张力减退和精神运动发育迟缓的婴儿(特别是伴有面部畸形、肝肿大、白内障和/或视网膜病变、点状钙化、肢体短小或这些特征的组合)、患有进行性神经功能障碍的学龄儿童以及患有缓慢进行性运动功能障碍的成年人,在鉴别诊断时应考虑这些疾病。目前对过氧化物酶体生化和酶促过程的了解允许在过氧化物酶体病分组中精确识别特定疾病。应努力确定具体的过氧化物酶体病,以便为神经发育缺陷提供精确解释,通过遗传咨询潜在地预防复发,并在有可用治疗方法时提供适当治疗。